Vous avez cherché: birth defect (Anglais - Maltais)

birth defects
difetti tat-twelid

risk of severe birth defects.
riskju ta’ difetti gravi fit-twelid.

multiple births or birth defects
twelid multiplu jew difetti tat-twelid

embryofoetal death or severe birth defects
mewta embrijofetali jew difetti gravi fit-twelid

erivedge may cause severe birth defects.
erivedge jista’ jikkawża difetti severi tat-twelid.

five miscarriages and 2 birth defects (microcephaly and correctable heart defect) were reported in 42 pregnancies.
Ħames korrimenti u 2 difetti tat- twelid (mikrokefalija u difett fil-qalb korregibbli) ġew irrapportati f’42 tqala.

embryo-foetal death or severe birth defects
mewt tal-embriju-fetu jew difetti severi tat-twelid

ribavirin causes serious birth defects when administered during rod
ribavirin jikkawża difetti tat- twelid serji meta jingħata waqt it - tqala.

ribavirin causes serious birth defects when administered during pregnancy.
ribavirin jikkawża difetti tat-twelid serji meta jingħata waqt it-tqala.

clofarabine may cause serious birth defects when administered during pregnancy.
clofarabine għandu mnejn jikkawża difetti serji tat-twelid meta jingħata matul it-tqala.

a risk of birth defects for your unborn child cannot be completely excluded.
r-riskju li jista’ jkun hemm difetti għat-tarbija ġol-guf ma jistax jiġi kompletament.

paclitaxel is suspected to cause serious birth defects when administered during pregnancy.
paclitaxel hu ssuspettat li jista’ jikkawża difetti serji tat-twelid meta jingħata waqt it-tqala.

doxorubicin hydrochloride is suspected to cause serious birth defects when administered during pregnancy.
huwa maħsub li doxorubicin hydrochloride jikkawża difetti gravi tat-twelid meta jingħata waqt it-tqala.

paclitaxel may cause serious birth defects and should therefore not be used if you are pregnant.
paclitaxel jista’ jikkawża difetti serji fit-tarbija u għalhekk m’għandux jintuża jekk inti tqila.

norvir did not appear to increase the chance of developing birth defects compared to the general population.
ma deherx li norvir iżid iċ-ċans ta’ żvilupp ta’ difetti tat-twelid meta pparagunat mal-popolazzjoni ġenerali.

combination therapy with ribavirin: ribavirin causes serious birth defects when administered during pregnancy.
terapija kombinata ma’ ribavirin: ribavirin jikkawża difetti tat-twelid serji meta jingħata waqt it- tqala.

the active metabolite of leflunomide, a771726 is suspected to cause serious birth defects when administered during pregnancy.
il-prodott metaboliku attiv ta’ leflunomide a771726 kien huwa maħsub li jista’ jagħmel difetti serji tat-twelid meta jingħata waqt it-tqala.

thalidomide is a powerful human teratogen, inducing a high frequency of severe and life- threatening birth defects.
thalidomide huwa teratoġen uman qawwi, li jissensitizza frekwenzi għoljin li jistgħu jkunu ta’ periklu għal ħajja b’mankamenti mit-twelid.

birth defects after assisted reproductive technology (art) may be slightly higher than after spontaneous conceptions.
difetti tat-twelid wara teknoloġija riproduttiva assistita (art) jistgħu jkunu ftit ogħla milli wara konċepimenti spontanji.

erivedge may cause embryo-foetal death or severe birth defects when administered to a pregnant woman (see section 4.4).
erivedge jista’ jikkawża mewt tal-embriju-fetu jew difetti severi tat-twelid meta jingħata lil mara tqila (ara sezzjoni 4.4).